Recent studies strongly suggest that the cannabinoid system is a key player in cell growth control. Since the organ‐culture of human hair follicles (HF) offers an excellent, clinically relevant model for complex tissue interaction systems, we have asked whether the cannabinoid system plays a role in hair growth control. Here, we show that human scalp HF, intriguingly, are both targets and sources of endocan‐nabinoids. Namely, the endocannabinoid N‐arachido‐noylethanolamide (anandamide, AEA) as well as the exocannabinnoid Δ (9)‐tetrahydrocannabinol dose‐de‐pendently inhibited hair shaft elongation and the proliferation of hair matrix keratinocytes, and induced intraepithelial apoptosis and premature HF regression (catagen). These effects were inhibited by a selective antagonist of cannabinoid receptor‐1 (CB1). In contrast to CB2, CB1 was expressed in a hair cycle‐dependent manner in the human HF epithelium. Since we successfully identified the presence of endocannabinoids in human HF, our data strongly suggest that human HF exploit a CB1‐mediated endocannabinoid signaling system for negatively regulating their own growth. Clinically, CB1 agonists may therefore help to manage unwanted hair growth, while CB1 antagonists might counteract hair loss. Finally, human HF organ culture offers an instructive, physiologically relevant new research tool for dissecting “nonclassical” effects of endocannabinoids and their receptor‐mediated signaling in general.—Telek, A., Bíró, T., Bodó, E., Tóth, B. I., Borbíró, I., Kunos, G., Paus, R. Inhibition of human hair follicle growth by endo‐ and exocannabi‐noids. FASEB J. 21, 3534–3541 (2007)